DecisionView Raises Series D

DecisionView Inc., a San Francisco-based provider of business performance optimization applications for the life sciences market, has raised an undisclosed amount of Series D funding. Backers include Granite Ventures, Adobe Ventures and Aeris Capital. The company previously raised around $20 million since 2004. Past backers Partech International and FirstVentury were not mentioned in the press release.



DecisionView, Inc., the leading provider of business performance optimization applications for the Life Sciences industry, today announced the close of its Series D investment with Granite Ventures, Adobe Ventures and Aeris Capital.


“The continued confidence demonstrated by our venture capital partners — Granite Ventures, Adobe Ventures and Aeris Capital, further validates DecisionView’s business strategy and growth opportunity,” said Steve Andrade, CEO of DecisionView. “Their investment in DecisionView, especially during this dynamic global economic period, allows us to continue to remain acutely focused on our business strategy and deliver innovative solutions and value to the life sciences industry.”


The additional funding will be applied to DecisionView’s strategic growth opportunities for expanding its distinctive platform for improving the performance of clinical trials. This includes the Company’s flagship application, StudyOptimizer, the first Web-based clinical trial enrollment software that enables companies to optimize the clinical trial recruitment and enrollment process for greater predictability, faster cycle times and reduced costs.


“DecisionView’s software continues to make a positive and significant impact on the way life sciences companies approach their clinical studies,” said Chris Hollenbeck, managing director, Granite Ventures. “With the increased economic and operational pressures on pharmaceutical companies today, DecisionView is poised for significant growth with product offerings that provide tangible value.”


“DecisionView is bringing truly unique applications to the clinical trial market and this financing will allow the company to continue to expand on their innovative offerings,” said David Hartford, managing director at Aeris Capital.


Recently, DecisionView announced several new features and enhancements to StudyOptimizer 4.0 including an innovative user interface framework, new analytic engine, an enterprise-class J2EE server and enhanced administration capabilities. StudyOptimizer 4.0 represented a major milestone for DecisionView with new features designed to improve user experience, performance, scalability and reliability.


About DecisionView, Inc.


DecisionView develops innovative software solutions that optimize the clinical performance of life sciences organizations around the world. By uniquely converging predictive analytics, simulation, visualization and data aggregation capabilities into functionally rich and easy to use applications, the company’s solutions deliver proven business value in faster cycle times, reducing clinical costs and improving clinical productivity. To learn more, visit


About Adobe Ventures


Adobe Ventures is a targeted venture capital fund supported by Adobe Systems Incorporated, the world’s leading provider of software solutions to create, manage and deliver high-impact, reliable digital content. Since 1994, Adobe Ventures has supported innovative companies that are strategic to Adobe’s business through a proven funding model leveraging its operational and investing expertise.


About Granite Ventures


Granite Ventures has been helping early-stage technology companies build solid foundations for success since 1992. They focus their investments in two sectors where their partners have deep domain expertise, broad industry knowledge, and significant investment experience: communications and components, and software. Granite has managed over $1 billion in venture capital and has invested in more than 90 private companies. They partner with promising and successful entrepreneurs to create businesses that have a competitive edge, and help those businesses achieve category leadership. For more information, visit